- Home
- CCEL vs NTWK Comparison
CCEL vs NTWK Comparison
Compare CCEL & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- NTWK
- Stock Information
- Founded
- CCEL 1989
- NTWK 1997
- Country
- CCEL United States
- NTWK United States
- Employees
- CCEL N/A
- NTWK N/A
- Industry
- CCEL Managed Health Care
- NTWK Computer Software: Prepackaged Software
- Sector
- CCEL Health Care
- NTWK Technology
- Exchange
- CCEL Nasdaq
- NTWK Nasdaq
- Market Cap
- CCEL 39.9M
- NTWK 33.8M
- IPO Year
- CCEL 1997
- NTWK 1998
- Fundamental
- Price
- CCEL $4.81
- NTWK $3.85
- Analyst Decision
- CCEL Strong Buy
- NTWK
- Analyst Count
- CCEL 1
- NTWK 0
- Target Price
- CCEL $8.50
- NTWK N/A
- AVG Volume (30 Days)
- CCEL 14.5K
- NTWK 44.5K
- Earning Date
- CCEL 07-15-2025
- NTWK 05-14-2025
- Dividend Yield
- CCEL 12.42%
- NTWK N/A
- EPS Growth
- CCEL N/A
- NTWK N/A
- EPS
- CCEL N/A
- NTWK 0.02
- Revenue
- CCEL $31,988,783.00
- NTWK $64,127,568.00
- Revenue This Year
- CCEL $2.49
- NTWK N/A
- Revenue Next Year
- CCEL $0.95
- NTWK N/A
- P/E Ratio
- CCEL N/A
- NTWK $186.62
- Revenue Growth
- CCEL 1.10
- NTWK 9.18
- 52 Week Low
- CCEL $4.68
- NTWK $2.14
- 52 Week High
- CCEL $9.43
- NTWK $4.30
- Technical
- Relative Strength Index (RSI)
- CCEL 43.31
- NTWK 68.08
- Support Level
- CCEL $4.75
- NTWK $3.53
- Resistance Level
- CCEL $5.05
- NTWK $3.93
- Average True Range (ATR)
- CCEL 0.19
- NTWK 0.25
- MACD
- CCEL -0.01
- NTWK 0.05
- Stochastic Oscillator
- CCEL 14.71
- NTWK 67.32
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.